സാബിൻ വാക്സിൻ ഇൻസ്റ്റിറ്റ്യൂട്ട് എന്ന താളിന്റെ മൂലരൂപം കാണുക

താങ്കൾക്ക് ഈ താൾ തിരുത്തുക എന്ന പ്രവൃത്തി ചെയ്യാൻ അനുമതി ഇല്ല, കാരണം താഴെ കൊടുത്തിരിക്കുന്നു:
Your IP address is in a range that has been blocked on all Wikimedia Foundation wikis.
The block was made by ‪EPIC‬. The reason given is Open proxy/Webhost: See the help page if you are affected.
Start of block: 08:48, 2 ജൂലൈ 2024
Expiry of block: 08:48, 2 ജൂലൈ 2025
Your current IP address is 206.189.44.186. The blocked range is 206.189.32.0/20.
Please include all above details in any queries you make. If you believe you were blocked by mistake, you can find additional information and instructions in the No open proxies global policy.
Otherwise, to discuss the block please post a request for review on Meta-Wiki. You could also send an email to the stewards VRT queue at stewards@wikimedia.org including all above details.
താങ്കൾക്ക് ഈ താളിന്റെ മൂലരൂപം കാണാനും പകർത്താനും സാധിക്കും.
{{prettyurl|Sabin Vaccine Institute}}
{{Infobox organization
| name =             Sabin Vaccine Institute
| native_name =      <!-- Organization's name in its local language -->
| native_name_lang =      <!-- ISO code of the above language -->
| named_after =      [[Albert Sabin|Albert B. Sabin]]<ref name="mmrf" /><ref>{{Cite web|title=Eradicating Polio: When Two Jewish Researchers Changed the World|url=https://www.aish.com/jw/s/Eradicating-Polio-When-Two-Jewish-Researchers-Changed-the-World.html|last=Miller|first=Dr Yvette Alt|date=2020-03-17|website=aishcom|language=en|access-date=2020-05-20}}</ref>
| image =  Sabinlogo-highres.jpg 
| image_size = 
| alt =              <!-- see [[WP:ALT]] -->
| caption = 
| map =              <!-- map image -->
| map_size =         <!-- defaults to 250px -->
| map_alt = 
| map_caption = 
| map2 =             <!-- second map image, if required -->
| map2_size = 
| map2_alt = 
| map2_caption = 
| abbreviation = 
| motto = 
| predecessor = 
| merged =           <!-- Any other organizations with which the organization was merged -->
| successor = 
| established =        {{start date and age|1993}}<ref name="heloisa" /><ref name="sabin_legacy" /><ref>{{Cite web|title=Sabin Institute To Develop GSK's Ebola and Marburg Virus Vaccines|url=https://www.precisionvaccinations.com/gsk-chad3-based-vaccines-against-ebola-zaire-ebola-sudan-and-marburg-viruses-demonstrated-strong|website=www.precisionvaccinations.com|language=en-US|access-date=2020-05-20}}</ref>
| founders =          
{{ublist|
Heloisa Sabin|
H.R. Shepherd|
[[Robert M. Chanock]]|
Philip Russell}} <!-- or: | founders = -->
| founding_location = 
| extinction =       <!-- or: | dissolved = -->   <!--e.g. use {{end date and age|YYYY|MM|DD}}-->
| merger =           <!-- Other organizations (if any) merged to constitute the organization -->
| type =             [[Charitable organization]]<!-- e.g. [[Governmental organization]], [[Non-governmental organization|NGO]], etc -->
| status =           <!-- Organization's legal status and/or description (company, charity, foundation, etc) -->
| purpose =          vaccination and disease prevention<!-- or: | focus = -->       <!--(humanitarian, activism, peacekeeping, etc)-->
| professional_title = <!-- for professional associations -->
| headquarters =       [[Washington, D.C.]]
| location = 
| coords =           {{Coord|38.9002964|-77.0460199|display=title,inline|format=dms|type:landmark}}<!-- location's {{coord}}s -->
| region =           <!-- or: | region_served = --> <!--Any particular region or regions associated with or served by the organization-->
| services = 
| membership =       <!-- Usually the number of members -->
| membership_year =  <!-- Year to which membership number/data apply -->
| language =         <!-- or: | languages = --> <!--Any official language or languages used by the organization-->
| sec_gen =          <!-- Name of the organization's Secretary General (if post exists) -->
| leader_title =     [[CEO]]<!-- defaults to "Leader" -->
| leader_name =      Amy Finan
| leader_title2 = 
| leader_name2 = 
| leader_title3 = 
| leader_name3 = 
| leader_title4 = 
| leader_name4 = 
| board_of_directors = 
| key_people =
| main_organ =       <!-- or: | publication = --> <!--Organization's principal body (assembly, committee, board, etc) or publication-->
| parent_organization =  <!-- or: | parent_organisation = -->
| subsidiaries = 
| secessions = 
| affiliations = 
| budget = 
| budget_year = 
| staff =            <!-- Numbers and/or types of staff -->
| staff_year =       <!-- Year to which staff numbers/data apply -->
| volunteers =       <!-- Numbers and/or types of volunteers -->
| volunteers_year =  <!-- Year to which volunteer numbers/data apply -->
| slogan =           <!-- in quotemarks / inverted commas -->
| website =          {{URL|http://www.sabin.org}}
| remarks = 
| formerly =         <!-- Any former names by which the organization known -->
| footnotes = 
}}
ആഗോള വാക്സിൻ വികസനം, ലഭ്യത, ഉപയോഗം എന്നിവ പ്രോത്സാഹിപ്പിക്കുന്ന ലാഭരഹിത സ്ഥാപനമാണ് വാഷിംഗ്ടൺ ഡി.സിയിൽ സ്ഥിതി ചെയ്യുന്ന '''സാബിൻ വാക്സിൻ ഇൻസ്റ്റിറ്റ്യൂട്ട്''' (സാബിൻ). മനുഷ്യരിൽ [[Herd immunity|ഹെർഡ് ഇമ്മ്യൂണിറ്റി]]യിലൂടെയും [[വാക്സിനാൽ തടയാൻ കഴിയുന്ന രോഗം|വാക്സിനാൽ തടയാൻ കഴിയുന്ന സാംക്രമികരോഗങ്ങൾ]] പടരുന്നത് തടയുന്നതിലൂടെയും ഈ രോഗങ്ങൾ മൂലമുണ്ടാകുന്ന ദാരിദ്ര്യം ലഘൂകരിക്കുന്നതിലൂടെയും മനുഷ്യരുടെ കഷ്ടപ്പാടുകൾ കുറയ്ക്കുമെന്ന് സാബിൻ അതിന്റെ പ്രവർത്തനത്തിലൂടെ പ്രതീക്ഷിക്കുന്നു.

== പശ്ചാത്തലം == 
ഓറൽ പോളിയോ വാക്സിൻ സ്രഷ്ടാവായ [[ആൽബെർട്ട് സാബിൻ|ആൽബർട്ട് ബി. സാബിന്റെ]] ബഹുമാനാർത്ഥം 1993-ൽ സ്ഥാപിതമായ<ref name="heloisa" /><ref name="sabin_legacy" /><ref>{{Cite web|title=Sabin Institute To Develop GSK's Ebola and Marburg Virus Vaccines|url=https://www.precisionvaccinations.com/gsk-chad3-based-vaccines-against-ebola-zaire-ebola-sudan-and-marburg-viruses-demonstrated-strong|website=www.precisionvaccinations.com|language=en-US|access-date=2020-05-20}}</ref> സാബിൻ വാക്സിൻ ഇൻസ്റ്റിറ്റ്യൂട്ട് വാക്സിന് തടയാൻ കഴിയുന്ന [[Neglected tropical diseases|നെഗ്ലെക്ടഡ് ട്രോപികൽ ഡിസീസെസ്]] (എൻടിഡി) മൂലം മനുഷ്യർ അനുഭവിക്കുന്ന ദുരിതങ്ങൾ കുറയ്ക്കുന്നതിന് പ്രവർത്തിക്കുന്നു.<ref name="mmrf" /><ref>{{Cite web|title=Eradicating Polio: When Two Jewish Researchers Changed the World|url=https://www.aish.com/jw/s/Eradicating-Polio-When-Two-Jewish-Researchers-Changed-the-World.html|last=Miller|first=Dr Yvette Alt|date=2020-03-17|website=aishcom|language=en|access-date=2020-05-20}}</ref>സാബിൻ വാക്സിൻ ഡവലപ്മെന്റ്, [[Global Network for Neglected Tropical Diseases|ഗ്ലോബൽ നെറ്റ്വർക്ക് ഓഫ് നെഗ്ലെക്ടഡ് ട്രോപികൽ ഡിസീസെസ്]], വാക്സിൻ അഡ്വക്കസി ആന്റ് എഡ്യൂക്കേഷൻ തുടങ്ങി മൂന്ന് പ്രധാന പ്രോഗ്രാമുകളിലൂടെ സംഘടന ലക്ഷ്യത്തിലെത്താൻ ശ്രമിക്കുന്നു. <ref name="sabin-iaim" />പ്രൊഡക്റ്റ് ഡവലപ്മെന്റ് പാർട്ണർഷിപ്പ് (പിഡിപി) വഴി സാബിൻ [[കിംഗ് സൌദ് യൂണിവേഴ്സിറ്റി|കിംഗ് സൗദ് യൂണിവേഴ്സിറ്റി]],<ref name="embassy" /> ടെക്സസ് ചിൽഡ്രൻസ് ഹോസ്പിറ്റൽ സെന്റർ, <ref name="kleberg" />  [[International Vaccine Institute|ഇന്റർനാഷണൽ വാക്സിൻ ഇൻസ്റ്റിറ്റ്യൂട്ട്]], <ref name="ivi" /> [[George Washington University School of Medicine & Health Sciences|ജോർജ്ജ് വാഷിംഗ്ടൺ യൂണിവേഴ്സിറ്റി സ്കൂൾ ഓഫ് മെഡിസിൻ & ഹെൽത്ത് സയൻസസ്]] <ref name="gates_foundation" />പോലുള്ള സംഘടനകളുമായി പ്രവർത്തിച്ചിട്ടുണ്ട്. [[Bill & Melinda Gates Foundation|ബിൽ & മെലിൻഡ ഗേറ്റ്സ് ഫൗണ്ടേഷന്റെയും]] <ref name="gates_foundation" /><ref name="gates_foundation2" /> [[National Institute of Allergy and Infectious Diseases|നാഷണൽ ഇൻസ്റ്റിറ്റ്യൂട്ട് ഓഫ് അലർജി ആൻഡ് ഇൻഫെക്ഷിയസ് ഡിസീസെസ്]], <ref name="bcm_chik" />[[Ministry of Foreign Affairs (Netherlands)|ഡച്ച് വിദേശകാര്യ മന്ത്രാലയം]], <ref name="vaccine_v31_sup2" /> [[List of federal institutions of Brazil|ബ്രസീലിയൻ ആരോഗ്യ മന്ത്രാലയം]] <ref name="vaccine_v31_sup2" /> എന്നിവയും മറ്റ് അഭ്യുദയകാംക്ഷികളും ധനസഹായവും പിന്തുണയും നൽകുന്നു.

== വാക്സിൻ വികസനവും ഗവേഷണവും ==
ഏഷ്യ, ആഫ്രിക്ക, അമേരിക്ക എന്നിവിടങ്ങളിലെ ഗവേഷണങ്ങൾ, വികസനം, പ്രമോഷൻ എഫർറ്റ് എന്നിവ സംയോജിപ്പിക്കുന്നതിന് 2012 ൽ സാബിൻ ഇന്റർനാഷണൽ വാക്സിൻ ഇൻസ്റ്റിറ്റ്യൂട്ടുമായി സഹകരിച്ചു.<ref name="ivi" />ഹുക്ക് വാം അണുബാധയ്ക്കുള്ള വാക്സിനുകൾ (നാ-ജിഎസ്ടി -1, നാ-എപിആർ -1)<ref name="gates_foundation" /><ref name="vaccine_v31_sup2" /><ref name="who" /><ref name="ctgov_hookworm" />, [[Schistosomiasis|ഷിസ്റ്റോസോമിയാസിസ്]] (എസ്എം-ടിഎസ്പി -2)<ref name="pnv" /><ref name="vaccine_v34_i26" /><ref name="ctgov_schisto1" /><ref name="ctgov_schisto1b" />  [[Chagas disease|ചഗാസ് ഡിസീസ്]] (ടിസി 24, ടിഎസ്എ -1)<ref name="kleberg" /><ref name="vaccine_v34_i26_2" /><ref name="sabin_chagas" />, ലീഷ്മാനിയാസിസ്(Ld-NH36, PdSP15) <ref name="vaccine_v34_i26_3" /><ref name="plos_ntd_v11_i3" /><ref name="sabin_leish" /> സീവിയർ അക്യൂട്ട് റെസ്പിറേറ്ററി സിൻഡ്രോം (SARS) / മിഡിൽ ഈസ്റ്റ് റെസ്പിറേറ്ററി സിൻഡ്രോം (MERS) (പാൻ-β-കോവാക്സ്)<ref name="expertreview_v11_i12" /><ref name="hvi_v10_i3" /><ref name="sabin_sars" /> , [[Soil-transmitted helminthiasis|സോയിൽ ട്രാൻസ്മിറ്റെഡ് ഹെൽമിൻതിയാസിസ്]] (STH), <ref name="expertreview_v13_i3" /><ref name="mmrf-helminth" /> [[Onchocerciasis|ഓങ്കോസെർസിയാസിസ്]] (Ov-103, Ov-RAL-2)<ref name="sabin_oncho" /><ref name="plos_oncho" /><ref name="tova" /><ref name="eid_oncho" />ഉൾപ്പെടെ മനുഷ്യർക്കായി നിരവധി വാക്‌സിനുകളിൽ സാബിൻ പ്രവർത്തിക്കുന്നു.

== അവലംബം==
{{Reflist|refs=

<ref name="heloisa">{{cite web|title=In Memoriam: Heloisa Sabin|url=http://www.sabin.org/updates/pressreleases/memoriam-heloisa-sabin|website=Sabin|accessdate=6 September 2017|language=en|archive-date=2021-05-12|archive-url=https://web.archive.org/web/20210512193744/https://www.sabin.org/updates/pressreleases/memoriam-heloisa-sabin|url-status=dead}}</ref>

<ref name="sabin_legacy">{{cite web|title=The Legacy of Albert B. Sabin|url=http://www.sabin.org/legacy-albert-b-sabin|website=Sabin|accessdate=6 September 2017|language=en}}</ref>

<ref name="mmrf">{{cite web|title=SABIN Vaccine Institute|url=https://michelsonmedical.org/who-we-are/beneficiaries/sabin-vaccine-institute/|website=[[Michelson Medical Research Foundation]]|accessdate=2 September 2017}}{{പ്രവർത്തിക്കാത്ത കണ്ണി|date=ഒക്‌ടോബർ 2022 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>

<ref name="sabin-iaim">{{cite web|title=Immunization Manager Network|url=http://www.sabin.org/programs/immunization-manager-network|website=Sabin|accessdate=2 September 2017|language=en|archive-date=2020-12-04|archive-url=https://web.archive.org/web/20201204212359/https://www.sabin.org/programs/immunization-manager-network|url-status=dead}}</ref>

<ref name="embassy">{{cite web|title=Sabin PDP, King Saud University Sign Project Agreement to Build Vaccine Research and Development Capacity in Saudi Arabia|url=https://sa.usembassy.gov/sabin-pdp-king-saud-university-sign-project-agreement-to-build-vaccine-research-and-development-capacity-in-saudi-arabia/|website=U.S. Embassy & Consulates in Saudi Arabia|accessdate=9 September 2017|archiveurl=https://web.archive.org/web/20170909002852/https://sa.usembassy.gov/sabin-pdp-king-saud-university-sign-project-agreement-to-build-vaccine-research-and-development-capacity-in-saudi-arabia/|archivedate=9 September 2017|date=16 November 2015}}</ref>

<ref name="ivi">{{cite web|title=IVI and Sabin Vaccine Institute Form a Strategic Alliance to Develop Vaccines for the World's Poor|url=http://www.ivi.int/?mod=document&uid=276&page_id=12426|website=International Vaccine Institute|accessdate=6 September 2017|archiveurl=https://web.archive.org/web/20170906202653/http://www.ivi.int/?mod=document&uid=276&page_id=12426|archivedate=6 September 2017|date=18 July 2012}}</ref>

<ref name="vaccine_v31_sup2">{{cite journal|last1=Hotez|first1=Peter J.|last2=Diemert|first2=David|last3=Bacon|first3=Kristina M.|last4=Beaumier|first4=Coreen|last5=Bethony|first5=Jeffrey M.|last6=Bottazzi|first6=Maria Elena|last7=Brooker|first7=Simon|last8=Couto|first8=Artur Roberto|last9=da Silva Freire|first9=Marcos|last10=Homma|first10=Akira|last11=Lee|first11=Bruce Y.|last12=Loukas|first12=Alex|last13=Loblack|first13=Marva|last14=Morel|first14=Carlos Medicis|last15=Oliveira|first15=Rodrigo Correa|last16=Russell|first16=Philip K.|title=The Human Hookworm Vaccine|journal=[[Vaccine (journal)|Vaccine]]|date=18 April 2013|volume=31|issue=Suppl 2|pages=B227–B232|doi=10.1016/j.vaccine.2012.11.034|pmc=3988917|issn=0264-410X|pmid=23598487}}</ref>

<ref name="gates_foundation">{{cite web|title=Hookworm Vaccine Research|url=https://www.gatesfoundation.org/Media-Center/Press-Releases/2000/08/Hookworm-Vaccine-Research|website=[[Bill & Melinda Gates Foundation]]|accessdate=8 September 2017|archiveurl=https://web.archive.org/web/20150911144857/http://www.gatesfoundation.org/Media-Center/Press-Releases/2000/08/Hookworm-Vaccine-Research|archivedate=11 September 2015|language=en}}</ref>

<ref name="who">{{cite web|title=Status of Vaccine Research and Development of Vaccines for Human Hookworm Infection|url=https://www.who.int/immunization/research/meetings_workshops/Human_hookworm_infection_vaccineRD_Sept2014.pdf|website=World Health Organization|accessdate=8 September 2017|archiveurl=https://web.archive.org/web/20170830045043/http://www.who.int/immunization/research/meetings_workshops/Human_hookworm_infection_vaccineRD_Sept2014.pdf|archivedate=30 August 2017}}</ref>

<ref name="pnv">{{cite journal|last1=Tebeje|first1=Biniam Mathewos|last2=Harvie|first2=Marina|last3=You|first3=Hong|last4=Loukas|first4=Alex|last5=McManus|first5=Donald P.|title=Schistosomiasis vaccines: where do we stand?|journal=[[Parasites & Vectors]]|date=30 September 2016|volume=9|issue=1|pages=528|doi=10.1186/s13071-016-1799-4|url= |accessdate=8 September 2017|issn=1756-3305|pmc=5045607|pmid=27716365}}</ref>

<ref name="vaccine_v34_i26">{{cite journal|last1=Merrifield|first1=Maureen|last2=Hotez|first2=Peter J.|last3=Beaumier|first3=Coreen M.|last4=Gillespie|first4=Portia|last5=Strych|first5=Ulrich|last6=Hayward|first6=Tara|last7=Bottazzi|first7=Maria Elena|title=Advancing a vaccine to prevent human schistosomiasis|journal=Vaccine|date=3 June 2016|volume=34|issue=26|pages=2988–2991|doi=10.1016/j.vaccine.2016.03.079|pmid=27036511|issn=1873-2518|doi-access=free}}</ref>

<ref name="vaccine_v34_i26_2">{{cite journal|last1=Beaumier|first1=Coreen M.|last2=Gillespie|first2=Portia M.|last3=Strych|first3=Ulrich|last4=Hayward|first4=Tara|last5=Hotez|first5=Peter J.|last6=Bottazzi|first6=Maria Elena|title=Status of vaccine research and development of vaccines for Chagas disease|journal=Vaccine|date=3 June 2016|volume=34|issue=26|pages=2996–3000|doi=10.1016/j.vaccine.2016.03.074|pmid=27026146|issn=1873-2518|doi-access=free}}</ref>

<ref name="kleberg">{{cite web|title=Texas Children's Hospital Center for Vaccine Development awarded grant to develop therapeutic vaccine for chagas disease|url=http://www.klebergfoundation.org/texas-childrens-hospital-center-for-vaccine-development-awarded-grant-to-develop-therapeutic-vaccine-for-chagas-disease/|website=Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation|accessdate=8 September 2017|archiveurl=https://web.archive.org/web/20160728002936/http://www.klebergfoundation.org/texas-childrens-hospital-center-for-vaccine-development-awarded-grant-to-develop-therapeutic-vaccine-for-chagas-disease/|archivedate=28 July 2016|date=17 July 2015|url-status=dead|df=}}</ref>

<ref name="vaccine_v34_i26_3">{{cite journal|last1=Gillespie|first1=Portia M.|last2=Beaumier|first2=Coreen M.|last3=Strych|first3=Ulrich|last4=Hayward|first4=Tara|last5=Hotez|first5=Peter J.|last6=Bottazzi|first6=Maria Elena|title=Status of vaccine research and development of vaccines for leishmaniasis|journal=Vaccine|date=3 June 2016|volume=34|issue=26|pages=2992–2995|doi=10.1016/j.vaccine.2015.12.071|pmid=26973063|issn=1873-2518|doi-access=free}}</ref>

<ref name="plos_ntd_v11_i3">{{cite journal|last1=Asojo|first1=Oluwatoyin A.|last2=Kelleher|first2=Alan|last3=Liu|first3=Zhuyun|last4=Pollet|first4=Jeroen|last5=Hudspeth|first5=Elissa M.|last6=Rezende|first6=Wanderson C.|last7=Groen|first7=Mallory Jo|last8=Seid|first8=Christopher A.|last9=Abdeladhim|first9=Maha|last10=Townsend|first10=Shannon|last11=Castro|first11=Waldione de|last12=Mendes-Sousa|first12=Antonio|last13=Bartholomeu|first13=Daniella Castanheira|last14=Fujiwara|first14=Ricardo Toshio|last15=Bottazzi|first15=Maria Elena|last16=Hotez|first16=Peter J.|last17=Zhan|first17=Bin|last18=Oliveira|first18=Fabiano|last19=Kamhawi|first19=Shaden|last20=Valenzuela|first20=Jesus G.|title=Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis|journal=PLOS Neglected Tropical Diseases|date=9 March 2017|volume=11|issue=3|pages=e0005374|doi=10.1371/journal.pntd.0005374|url=http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0005374|accessdate=8 September 2017|issn=1935-2735|pmc=5344329|pmid=28278244}}</ref>

<ref name="expertreview_v11_i12">{{cite journal|last1=Jiang|first1=Shibo|last2=Bottazzi|first2=Maria Elena|last3=Du|first3=Lanying|last4=Lustigman|first4=Sara|last5=Tseng|first5=Chien-Te Kent|last6=Curti|first6=Elena|last7=Jones|first7=Kathryn|last8=Zhan|first8=Bin|last9=Hotez|first9=Peter J|title=Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome|journal=[[Expert Review of Vaccines]]|date=December 2012|volume=11|issue=12|pages=1405–1413|doi=10.1586/erv.12.126|pmc=3586247|issn=1476-0584|pmid=23252385}}</ref>

<ref name="hvi_v10_i3">{{cite journal|last1=Chen|first1=Wen-Hsiang|last2=Du|first2=Lanying|last3=Chag|first3=Shivali M.|last4=Ma|first4=Cuiqing|last5=Tricoche|first5=Nancy|last6=Tao|first6=Xinrong|last7=Seid|first7=Christopher A.|last8=Hudspeth|first8=Elissa M.|last9=Lustigman|first9=Sara|last10=Tseng|first10=Chien-Te K.|last11=Bottazzi|first11=Maria Elena|last12=Hotez|first12=Peter J.|last13=Zhan|first13=Bin|last14=Jiang|first14=Shibo|title=Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate|journal=[[Human Vaccines & Immunotherapeutics]]|date=2014|volume=10|issue=3|pages=648–658|pmid=24355931|issn=2164-554X|doi=10.4161/hv.27464|pmc=4130269}}</ref>

<ref name="expertreview_v13_i3">{{cite journal|last1=Zhan|first1=Bin|last2=Beaumier|first2=Coreen M|last3=Briggs|first3=Neima|last4=Jones|first4=Kathryn M|last5=Keegan|first5=Brian P|last6=Bottazzi|first6=Maria Elena|last7=Hotez|first7=Peter J|title=Advancing a multivalent 'Pan-anthelmintic' vaccine against soil-transmitted nematode infections|journal=Expert Review of Vaccines|date=2014|volume=13|issue=3|pages=321–331|doi=10.1586/14760584.2014.872035|pmc=3934375|issn=1476-0584|pmid=24392641}}</ref>

<ref name="mmrf-helminth">{{cite web|title=Helminth Vaccine Discovery Program funded by Dr. Gary K. Michelson|url=https://michelsonmedical.org/2014/04/27/gary-michelson-funding-development-soil-transmitted-helminth-vaccine/|website=Michelson Medical Research Foundation|accessdate=8 September 2017|date=27 April 2014}}{{പ്രവർത്തിക്കാത്ത കണ്ണി|date=ഒക്‌ടോബർ 2022 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>



<ref name="sabin_oncho">{{cite web|title=Onchocerciasis|url=http://www.sabin.org/programs/onchocerciasis|website=Sabin|accessdate=11 September 2017|archiveurl=https://web.archive.org/web/20170712124418/http://www.sabin.org/programs/onchocerciasis|archivedate=12 July 2017|language=en}}</ref>

<ref name="plos_oncho">{{cite journal|last1=Hotez|first1=Peter J.|last2=Bottazzi|first2=Maria Elena|last3=Zhan|first3=Bin|last4=Makepeace|first4=Benjamin L.|last5=Klei|first5=Thomas R.|last6=Abraham|first6=David|last7=Taylor|first7=David W.|last8=Lustigman|first8=Sara|title=The Onchocerciasis Vaccine for Africa—TOVA—Initiative|journal=PLOS Neglected Tropical Diseases|date=29 January 2015|volume=9|issue=1|pages=e0003422|doi=10.1371/journal.pntd.0003422|url=http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0003422|accessdate=11 September 2017|issn=1935-2735|pmid=25634641|pmc=4310604}}</ref>

<ref name="tova">{{cite web|title=The Partners|url=http://www.riverblindnessvaccinetova.org/partners|website=The Onchocerciasis Vaccine for Africa Initiative|accessdate=11 September 2017|archiveurl=https://web.archive.org/web/20170214145404/http://www.riverblindnessvaccinetova.org/partners|archivedate=14 February 2017|language=en}}</ref>

<ref name="eid_oncho">{{cite web|title=The Onchocerciasis Vaccine for Africa (TOVA) - A global initiative to advance river blindness vaccine|url=http://www.eid.ed.ac.uk/eid/news/TOVA|website=Edinburgh Infectious Diseases|accessdate=11 September 2017|archiveurl=https://web.archive.org/web/20170911213348/http://www.eid.ed.ac.uk/eid/news/TOVA|archivedate=11 September 2017|date=27 August 2015}}</ref>




<ref name="ctgov_hookworm">{{cite web|title=Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children - Full Text View|url=https://clinicaltrials.gov/ct2/show/NCT02839161|website=clinicaltrials.gov|accessdate=18 September 2017|archiveurl=https://web.archive.org/web/20170918182441/https://clinicaltrials.gov/ct2/show/NCT02839161|archivedate=18 September 2017|language=en}}</ref>

<ref name="ctgov_schisto1">{{cite web|title=A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults - Full Text View|url=https://clinicaltrials.gov/ct2/show/study/NCT02337855|website=ClinicalTrials.gov|accessdate=18 September 2017|archiveurl=https://web.archive.org/web/20170918182703/https://clinicaltrials.gov/ct2/show/study/NCT02337855|archivedate=18 September 2017|language=en}}</ref>

<ref name="ctgov_schisto1b">{{cite web|title=A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults - Full Text View|url=https://clinicaltrials.gov/ct2/show/study/NCT03110757|website=ClinicalTrials.gov|accessdate=18 September 2017|archiveurl=https://web.archive.org/web/20170918182816/https://clinicaltrials.gov/ct2/show/study/NCT03110757|archivedate=18 September 2017|language=en}}</ref>

<ref name="sabin_chagas">{{cite web|title=Chagas|url=http://www.sabin.org/programs/chagas|website=Sabin|accessdate=18 September 2017|archiveurl=https://web.archive.org/web/20170712113323/http://www.sabin.org/programs/chagas|archivedate=12 July 2017|language=en}}</ref>

<ref name="sabin_leish">{{cite web|title=Leishmaniasis|url=http://www.sabin.org/programs/leishmaniasis|website=Sabin|accessdate=18 September 2017|archiveurl=https://web.archive.org/web/20170712124326/http://www.sabin.org/programs/leishmaniasis|archivedate=12 July 2017|language=en}}</ref>

<ref name="sabin_sars">{{cite web|title=SARS/MERS|url=http://www.sabin.org/programs/sarsmers|website=Sabin|accessdate=18 September 2017|archiveurl=https://web.archive.org/web/20170712124505/http://www.sabin.org/programs/sarsmers|archivedate=12 July 2017|language=en}}</ref>

<ref name="gates_foundation2">{{cite web|title=Sabin Vaccine Colloquium|url=https://www.gatesfoundation.org/Media-Center/Press-Releases/2000/05/Sabin-Vaccine-Colloquium|website=Bill & Melinda Gates Foundation|accessdate=20 September 2017|archiveurl=https://web.archive.org/web/20150920193811/http://www.gatesfoundation.org/Media-Center/Press-Releases/2000/05/Sabin-Vaccine-Colloquium|archivedate=20 September 2015|language=en}}</ref>



<ref name="bcm_chik">{{cite web|author1=Dipali Pathak|title=Grant to develop chikungunya virus vaccine awarded|url=https://www.bcm.edu/news/grants/grant-chikungunya-virus-vaccine|website=Baylor College of Medicine|accessdate=3 October 2017|archiveurl=https://web.archive.org/web/20170520080133/https://www.bcm.edu/news/grants/grant-chikungunya-virus-vaccine|archivedate=20 May 2017|language=en|date=30 August 2016}}</ref>



}}

== പുറംകണ്ണികൾ ==
*{{URL|https://www.facebook.com/sabinvaccine/|Sabin Vaccine Institute on Facebook}}
*{{URL|https://twitter.com/sabinvaccine|Sabin Vaccine Institute on Twitter}}
ഈ താളിൽ ഉപയോഗിച്ചിരിക്കുന്ന ഫലകങ്ങൾ:
സാബിൻ വാക്സിൻ ഇൻസ്റ്റിറ്റ്യൂട്ട് എന്ന താളിലേക്ക് മടങ്ങുക.
"https://ml.wikipedia.org/wiki/സാബിൻ_വാക്സിൻ_ഇൻസ്റ്റിറ്റ്യൂട്ട്" എന്ന താളിൽനിന്ന് ശേഖരിച്ചത്